Cisplatinum/Pemetrexed Versus Split-dose Cisplatinum/Pemetrexed In NSCLC

NCT01742767 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Cisplatinum
DRUG: Pemetrexed

Sponsor

Universität Duisburg-Essen

Collaborators

[object Object]